| 0.6 |
1.9 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 0.5 |
2.1 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 0.4 |
1.2 |
GO:0072223 |
metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
| 0.4 |
1.1 |
GO:0035604 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) |
| 0.3 |
1.0 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.3 |
0.9 |
GO:1901254 |
positive regulation of intracellular transport of viral material(GO:1901254) |
| 0.3 |
0.9 |
GO:0033364 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) mast cell secretory granule organization(GO:0033364) |
| 0.3 |
1.4 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.3 |
1.3 |
GO:0090273 |
regulation of somatostatin secretion(GO:0090273) |
| 0.3 |
1.0 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.3 |
1.3 |
GO:1900170 |
prolactin signaling pathway(GO:0038161) negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 0.3 |
1.3 |
GO:0042117 |
monocyte activation(GO:0042117) |
| 0.2 |
0.6 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.2 |
1.1 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.2 |
1.0 |
GO:1905049 |
negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
| 0.2 |
0.5 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) positive regulation of macrophage apoptotic process(GO:2000111) |
| 0.2 |
2.3 |
GO:0060693 |
regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.2 |
0.6 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.1 |
1.1 |
GO:0060746 |
parental behavior(GO:0060746) |
| 0.1 |
0.3 |
GO:0032240 |
negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.1 |
0.3 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.1 |
0.5 |
GO:0002667 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) negative regulation of protein kinase C signaling(GO:0090038) |
| 0.1 |
0.8 |
GO:0061669 |
spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.1 |
1.2 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.1 |
0.6 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.1 |
0.2 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 |
0.3 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.1 |
1.0 |
GO:1904293 |
negative regulation of ERAD pathway(GO:1904293) |
| 0.1 |
0.2 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.1 |
0.2 |
GO:0035878 |
nail development(GO:0035878) |
| 0.1 |
1.0 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 |
0.7 |
GO:2001014 |
regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.1 |
0.2 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.1 |
0.1 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.1 |
1.6 |
GO:0031571 |
mitotic G1 DNA damage checkpoint(GO:0031571) |
| 0.1 |
0.5 |
GO:0036371 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 0.0 |
0.5 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 0.0 |
0.6 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.0 |
0.2 |
GO:0090148 |
membrane fission(GO:0090148) |
| 0.0 |
0.1 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 0.0 |
0.6 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.0 |
0.3 |
GO:0061084 |
negative regulation of protein refolding(GO:0061084) |
| 0.0 |
1.7 |
GO:0045604 |
regulation of epidermal cell differentiation(GO:0045604) |
| 0.0 |
0.2 |
GO:2000015 |
regulation of determination of dorsal identity(GO:2000015) |
| 0.0 |
0.7 |
GO:0003094 |
glomerular filtration(GO:0003094) |
| 0.0 |
0.5 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.0 |
0.1 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.0 |
0.1 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) |
| 0.0 |
0.8 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.0 |
0.4 |
GO:0002467 |
germinal center formation(GO:0002467) |
| 0.0 |
0.0 |
GO:1990314 |
pyrimidine-containing compound transmembrane transport(GO:0072531) cellular response to insulin-like growth factor stimulus(GO:1990314) |
| 0.0 |
0.2 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.0 |
1.9 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.0 |
0.1 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.0 |
0.2 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.0 |
0.3 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 |
0.1 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.0 |
0.1 |
GO:0014012 |
negative regulation of Schwann cell proliferation(GO:0010626) peripheral nervous system axon regeneration(GO:0014012) |
| 0.0 |
0.5 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.4 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.0 |
0.5 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 |
0.2 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 |
0.4 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.0 |
0.4 |
GO:0032757 |
positive regulation of interleukin-8 production(GO:0032757) positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.0 |
0.3 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.0 |
0.1 |
GO:0042795 |
snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.0 |
0.6 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.0 |
0.3 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.0 |
0.4 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.0 |
0.3 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 0.0 |
0.1 |
GO:0044340 |
canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.0 |
0.6 |
GO:0060351 |
cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.0 |
0.6 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
1.0 |
GO:0007628 |
adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
| 0.0 |
0.3 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 |
2.5 |
GO:0008643 |
carbohydrate transport(GO:0008643) |
| 0.0 |
0.4 |
GO:0001709 |
cell fate determination(GO:0001709) |
| 0.0 |
0.5 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.0 |
0.1 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.0 |
0.0 |
GO:0002447 |
eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) regulation of eosinophil activation(GO:1902566) |
| 0.0 |
0.6 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 0.0 |
0.8 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.0 |
0.1 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.0 |
0.8 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.0 |
0.5 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.0 |
0.0 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.0 |
0.2 |
GO:1902895 |
positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
